<?xml version="1.0" encoding="UTF-8"?>
<p>Although very popular in East Asia, medicinal mushroom therapies are still largely unknown in Western countries, especially in conventional medical institutions. The medicinal use of mushrooms is becoming wide known within the CIM communities of Europe and the United States. The number of studies on medical mushrooms in oncology has increased in recent decades (
 <xref rid="B30" ref-type="bibr">Joseph et al., 2018</xref>). Apart from focusing on certain mushroom-derived mono-substances, such as PSP, lentinan and krestin, research into the entire spectrum of mushroom formulations is considered promising. The large number of active ingredients of medicinal mushrooms is suspected to synergistically act on several cancer-related pathways (
 <xref rid="B62" ref-type="bibr">Wasser, 2017</xref>; 
 <xref rid="B30" ref-type="bibr">Joseph et al., 2018</xref>).
</p>
